Chemoprevention of Balb/3T3 Sarcomas in Mice - Edward Bresnick

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: Division of Cancer Prevention And Control (NCI)
Type: Research and Development Contracts (N01)
Project #: N01CN055451-005003
Application #: 3620554
Study Section

Project Start: 1986-09-30
Project End
Budget Start: 1989-02-22
Budget End: 1989-03-31
Support Year
Fiscal Year: 1989
Total Cost
Indirect Cost

Institution

Name: University of Nebraska Medical Center
Department
Type: Overall Medical
DUNS #

City: Omaha
State: NE
Country: United States
Zip Code: 68198

Related projects


NIH 1990 N01 CN	Chemoprevention of Mam Acetate Induced Colon Cancer Tempero, Margaret / University of Nebraska Medical Center
NIH 1989 N01 CN	Chemoprevention of Balb/3T3 Sarcomas in Mice Bresnick, Edward / University of Nebraska Medical Center
NIH 1988 N01 CN	Chemoprevention of Mam Acetate Induced Colon Cancer Bresnick, Edward / University of Nebraska Medical Center
NIH 1987 N01 CN	Chemoprevention of Mam Acetate Induced Colon Cancer Bresnick, Edward / University of Nebraska Medical Center
NIH 1986 N01 CN	Chemoprevention of Balb/3T3 Sarcomas in Mice Bresnick, Edward / University of Nebraska Medical Center
NIH 1985 N01 CN	Chemoprevention of Mouse Colon Cancer Bresnick, Edward / University of Nebraska Medical Center

Publications

Tempero, M A; Haga, Y; Sivinski, C et al. (1995) Immunologic effects of levamisole in mice and humans: evidence for augmented antibody response without modulation of cellular cytotoxicity. J Immunother Emphasis Tumor Immunol 17:47-57

Comments

Be the first to comment on Edward Bresnick's grant